| Characteristics | Overall | No DR | NPDR | PDR | p-value | Adj.p-value |
---|---|---|---|---|---|---|---|
1 | Demographic and Baseline | Â | Â | Â | Â | Â | Â |
 | Age (years) | 54.43 ± 9.59 | 54.99 ± 10.55 | 54.45 ± 8.52 | 51.83 ± 8.09 | 0.15 | 0.44 |
 | Sex male (n,%) | 113 (42.64%) | 61 (23.02%) | 40 (15.09%) | 12 (4.53%) | 0.44 | 0.68 |
 | HT (n,%) | 109 (41.13%) | 43 (16.23%) | 48 (18.11%) | 18 (6.79%) | 0.0007 | *0.004 |
 | DM Duration (years) | 6.21 ± 6.37 | 5.88 ± 7.01 | 6.39 ± 5.50 | 7.03 ± 6.12 | 0.33 | 0.68 |
 | Systolic BP (mmHg) | 142.95 ± 21.68 | 138.8 ± 19.22 | 144.21 ± 22.07 | 157.47 ± 24.60 | < 0.0001 | *0.0002 |
 | Diastolic BP (mmHg) | 88.05 ± 11.78 | 86.09 ± 11.82 | 88.78 ± 10.08 | 94.4 ± 14.49 | 0.0004 | *0.003 |
 | Body Mass Index (Kg/m2) | 25.46 ± 4.81 | 26.34 ± 5.15 | 24.76 ± 4.19 | 23.87 ± 4.50 | 0.002 | *0.008 |
 | Heart Rate (bpm) | 78.18 ± 12.44 | 76.58 ± 12.51 | 78.6 ± 12.48 | 83.93 ± 10.32 | 0.004 | *0.02 |
2 | HbA1C and Lipid Profiles | Â | Â | Â | Â | Â | Â |
 | HbA1C (%) | 8.44 ± 2.06 | 7.99 ± 1.71 | 8.70 ± 2.16 | 9.48 ± 2.61 | < 0.0001 | *0.0003 |
 | Total Cholesterol (mg/dL) | 203.11 ± 47.66 | 201.02 ± 52.30 | 200.07 ± 43.51 | 221.65 ± 32.15 | 0.12 | 0.47 |
 | HDL-Cholesterol (mg/dL) | 54.35 ± 23.75 | 55.09 ± 23.44 | 54.11 ± 23.55 | 51.64 ± 26.33 | 0.50 | 0.99 |
 | LDL-Cholesterol (mg/dL) | 124.23 ± 39.08 | 122.78 ± 42.35 | 121.79 ± 35.47 | 138.24 ± 31.84 | 0.16 | 0.48 |
 | Triglyceride (mg/dL) | 160.58 ± 98.88 | 157.84 ± 99.89 | 160.16 ± 95.74 | 173.6 ± 105.88 | 0.49 | 0.99 |
3 | Renal Function | Â | Â | Â | Â | Â | Â |
 | eGFR (mL/min/1.73m2) | 66.78 ± 32.80 | 76.38 ± 34.12 | 58.74 ± 29.49 | 50.07 ± 22.37 | < 0.0001 | *<0.0001 |
 | Creatinine (mg/dL) | 1.30 ± 1.10 | 1.03 ± 0.42 | 1.54 ± 1.44 | 1.75 ± 1.57 | < 0.0001 | *<0.0001 |
4 | Arterial Stiffness | Â | Â | Â | Â | Â | Â |
 | Brachial-ankle PWV (m/s) | 15.49 ± 3.07 | 14.77 ± 2.64 | 15.74 ± 3.11 | 17.93 ± 3.42 | < 0.0001 | *<0.0001 |
 | Ankle Brachial Index (ABI) | 1.05 ± 0.12 | 1.04 ± 0.14 | 1.06 ± 0.12 | 1.07 ± 0.07 | 0.34 | 0.34 |
5 | Ophthalmic Examination | Â | Â | Â | Â | Â | Â |
 | BCVA (LogMAR) | 0.19 ± 0 0.43 | 0.09 ± 0.29 | 0.17 ± 0.39 | 0.66 ± 0.69 | < 0.0001 | *<0.0001 |
 | Spheriqal Equivalent | -0.002 ± 1.72 | -0.02 ± 1.77 | -0.13 ± 1.67 | 0.53 ± 1.58 | 0.45 | 0.45 |
 | Intraocular Pressure (mmHg) | 16.87 ± 2.90 | 17.10 ± 3.19 | 16.84 ± 2.53 | 15.86 ± 2.53 | 0.05 | 0.11 |
6 | Retinal Neurovascular | Â | Â | Â | Â | Â | Â |
 | Ave mGC-IPLt (µm) | 78.07 ± 14.17 | 79.49 ± 10.99 | 77.7 ± 13.28 | 72.44 ± 25.91 | 0.02 | 0.09 |
 | Ave RNFLt (µm) | 99.16 ± 18.85 | 98.25 ± 12.88 | 95.69 ± 19.46 | 116.75 ± 30.69 | 0.005 | *0.02 |
 | Vessel Density (VD) (%) |  |  |  |  |  |  |
 |  VD Central | 8.25 ± 3.32 | 8.33 ± 3.13 | 8.06 ± 3.39 | 8.53 ± 3.91 | 0.96 | 1.00 |
 |  VD Inner | 16.83 ± 2.41 | 17.26 ± 2.34 | 16.67 ± 2.31 | 15.45 ± 2.55 | 0.0001 | *0.001 |
 |  VD Outer | 17.15 ± 2.09 | 17.49 ± 2.17 | 16.91 ± 1.97 | 16.37 ± 1.89 | 0.002 | *0.01 |
 |  VD Full | 16.83 ± 2.10 | 17.19 ± 2.13 | 16.61 ± 2.00 | 15.95 ± 1.97 | 0.0009 | *0.007 |
 | Fovea Avascular Zone (FAZ) |  |  |  |  |  |  |
 |  FAZ Area (mm2) | 0.27 ± 0.13 | 0.28 ± 0.12 | 0.27 ± 0.13 | 0.27 ± 0.16 | 0.65 | 1.00 |
 |  FAZ Perimeter | 2.27 ± 1.26 | 2.31 ± 1.62 | 2.20 ± 0.68 | 2.27 ± 0.84 | 0.68 | 1.00 |
 |  FAZ Circularity Index | 0.68 ± 0.12 | 0.71 ± 0.10 | 0.67 ± 0.12 | 0.62 ± 0.12 | < 0.0001 | *0.0007 |